|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,626.25 INR | +5.31% |
|
-1.27% | +108.76% |
| 07-30 | Novartis India Ltd Announces Appointment of Vikas Gupta to CEO Role | CI |
| 07-30 | Novartis India Ltd Announces Management Changes | CI |
| Market Cap | 23.97B 251M 219M 204M 187M 353M 359M 2.41B 942M 11.95B 945M 924M 39.43B | P/E 2024 |
29.8x | P/E 2025 | 19.2x |
|---|---|---|---|---|---|
| Enterprise Value | 17.65B 185M 161M 150M 138M 260M 265M 1.77B 694M 8.8B 696M 680M 29.03B | EV / Sales 2024 |
5.85x | EV / Sales 2025 | 3.67x |
| Free-Float |
27.09% | Yield 2024 |
2.43% | Yield 2025 | 3.18% |
| 1 day | +5.31% | ||
| 1 week | -1.27% | ||
| Current month | +5.31% | ||
| 1 month | +11.95% | ||
| 3 months | +57.45% | ||
| 6 months | +112.65% | ||
| Current year | +108.76% |
| 1 week | 1,525.7 |  | 1,650.4 |
| 1 month | 1,437.7 | | 1,777.5 |
| Current year | 750 | | 1,777.5 |
| 1 year | 750 | | 1,777.5 |
| 3 years | 599.95 | | 1,777.5 |
| 5 years | 554 | | 1,777.5 |
| 10 years | 420.05 | | 1,777.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikas Gupta
CEO | Chief Executive Officer | - | 2026-07-29 |
Chandni Maru
CMP | Compliance Officer | - | 2024-05-07 |
Amitabh Dube
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ashok Bhatia
BRD | Director/Board Member | 72 | 2026-07-28 |
| Director/Board Member | - | 2026-07-28 | |
Jagriti Gupta
BRD | Director/Board Member | - | 2026-07-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.31% | -1.27% | +68.13% | +126.73% | 399M | |
| -2.39% | -6.36% | +45.82% | +149.66% | 1,024B | |
| -0.76% | -4.34% | +48.74% | +49.09% | 618B | |
| -2.33% | -4.60% | +24.30% | +64.44% | 443B | |
| +0.68% | +0.25% | +38.47% | +31.95% | 349B | |
| -1.66% | -1.89% | +32.18% | +37.17% | 297B | |
| -8.96% | -9.23% | +3.57% | +3.64% | 264B | |
| -1.37% | -5.71% | -2.10% | -44.43% | 209B | |
| -1.63% | +0.69% | +25.48% | +64.23% | 208B | |
| +0.72% | +0.48% | +14.53% | +73.64% | 162B | |
| Average | -1.32% | -1.84% | +29.91% | +55.61% | 357.42B | |
| Weighted average by Cap. | -1.90% | -2.17% | +33.29% | +70.34% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.35B 35.15M 30.55M 28.52M 26.19M 49.37M 50.23M 336M 132M 1.67B 132M 129M 5.51B | 3.56B 37.38M 32.48M 30.33M 27.84M 52.5M 53.41M 358M 140M 1.78B 140M 137M 5.86B |
| Net income | 852M 8.94M 7.77M 7.25M 6.66M 12.55M 12.77M 85.51M 33.49M 425M 33.57M 32.83M 1.4B | 1.01B 10.59M 9.2M 8.59M 7.89M 14.87M 15.13M 101M 39.67M 503M 39.76M 38.88M 1.66B |
| Net Debt | -5.78B -60.64M -52.7M -49.2M -45.17M -85.17M -86.66M -580M -227M -2.88B -228M -223M -9.51B | -6.32B -66.31M -57.63M -53.8M -49.39M -93.13M -94.75M -634M -248M -3.15B -249M -244M -10.4B |
Employees
56
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-03 | ₹1,626.25 | +5.31% | 3,162 |
| 26-07-31 | ₹1,544.30 | -1.82% | 3,863 |
| 26-07-30 | ₹1,572.85 | -1.44% | 2,125 |
| 26-07-29 | ₹1,595.75 | +1.07% | 2,207 |
| 26-07-28 | ₹1,578.90 | -3.08% | 1,129 |
- Stock Market
- Stocks
- NOVARTIND Stock
Select your edition
All financial news and data tailored to specific country editions
